Quinine.
Quinine is the bitter alkaloid from cinchona bark. In drinks and bitters formulas it works as a flavour compound at tightly limited levels rather than as an active amount.
- Category
- Herb
What Quinine is, and what it does.
- Does it work
- It suits people who want that classic dry bitter note in a drink or a bitters preparation. Above flavour level it sits with a prescriber rather than on a shelf.
- How much to take
- No daily supplement amount is on record, and none should be inferred. In drinks it is used at flavour level only, and anything beyond that is a prescribing decision.
- Time to feel it
- The bitterness registers within a second of it touching your tongue. Beyond taste, nobody has measured a supplement-scale timeline for it.
- The first dose
- Day one is the bitter taste, and that part is immediate. At flavour concentrations no further day-one effect has been measured in people.
- With regular use
- Nobody has measured what weeks of flavour-level quinine do. At prescription amounts the long view belongs to the clinician who wrote it.
- How well tolerated
- Quinine is linked to immune-mediated blood reactions, which is why several regulators restrict it off prescription. It also inhibits CYP2D6. Ask your doctor before any real amount.
- How it feels
- Intensely bitter, drying, with a faint metallic edge at the back of the palate. At flavour level that taste is the whole experience.
- The overlooked benefit
- It is the reference bitterant of sensory science, the yardstick every other bitter compound is measured against on human bitter taste receptors.
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
- Bitter taste receptor activationIn vitro study
- Occasional night-time muscle crampingMeta-analysis
- Skeletal muscle end plate excitabilityAnimal study
- Cardiac potassium channel activityIn vitro study
- CYP2D6 inhibition and the clearance of other substancesNarrative review
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Quinine reduces the excitability of the motor end plate and lengthens the refractory period of muscle fibre, which is the pharmacological reason it was historically taken for night-time muscle cramping. Magnesium acts at the neuromuscular junction by a different route. Taken together the effects point the same direction on paper. Regulators in several countries have restricted quinine for cramping because of blood disorder reports, so this pairing is documented history rather than a current recommendation.
Quinine alters calcium movement in muscle fibre, which is part of how it changes contraction and relaxation timing. The source index flags calcium co-occurrence as antagonistic rather than cooperative. That means the relationship is one to be aware of, not one to build a formula around. The direction and size of any effect at supplement-level intakes has not been characterised.
Quinine and its stereoisomer quinidine block potassium channels and prolong cardiac repolarisation, which is well documented pharmacology and the reason quinidine was used as an antiarrhythmic. The co-occurrence index flags potassium as antagonistic. Anyone taking potassium alongside a quinine-containing product should regard the combination as a cardiac electrophysiology question for a clinician. This is a caution, not a synergy.
Cinchona bark preparations contain condensed tannins alongside the alkaloids, and polyphenol binding of non-haem iron in the intestinal lumen is settled nutrition chemistry. A bitter bark tonic taken with a meal will reduce iron uptake from that meal. Purified quinine salts do not carry this liability because the tannins are removed. The distinction between bark and isolated alkaloid matters here.
Quinine is a reference agonist in bitter taste receptor research and activates TAS2R subtypes at low concentration. Bitter receptor stimulation is the classical mechanism behind aperitif bitters and gastric secretion. Enzyme preparations act further down the same digestive sequence by supplying hydrolytic capacity directly. The pairing is mechanistically coherent, and quinine at food-flavouring levels is the only intake relevant to it.
Nothing specific on file for Quinine. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Quinine actually does.
Quinine comes from cinchona bark, and its mirror-image relative quinidine differs by only a small structural detail yet acts very differently on the heart.
Quinine is used as the reference bitter compound for measuring taste receptor activation, which is also why it flavors tonic water, though only at tightly limited amounts.
Quinine and its relative quinidine can interfere with the heart's electrical rhythm, which is why quinidine has been used as a prescription heart-rhythm medicine and why this effect needs a prescriber's oversight, not self-directed use.
Quinine dampens the excitability of the nerve-muscle junction, which is the proposed reason it was historically used for nighttime muscle cramps.
Getting Quinine from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- A cinchona-based liquid formulation showed antifungal activity in the test system, reported as tryptophan starvation and mitochondrial disruption in the target organism.In vitro study. Das S et al., 2025 (Scientific Reports). PMID 41203652 ↗
These are the studies our verdict leans on, chosen from the 1 we read for Quinine. The full linked list is below.
The studies, linked.
12 sources behind our Quinine verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
- Clinical trialA Randomized Clinical Trial to Measure the Impact of Retreatment With an Artemisinin-based Combination on Malaria Incidence and Its Potential Selection of Resistant StrainsClinicalTrials.gov ↗Phase 3, 2,117 participants, Completed
- Clinical trialA Randomised Safety and Efficacy Trial of Rifampicin/Cotrimoxazole/Isoniazid Versus Mefloquine or Quinine+SP Against Resistant Malaria in Papua New GuineaClinicalTrials.gov ↗Phase 2, 330 participants, Terminated
- Clinical trialAssessment of Antimalaria Drugs Susceptibility Testing for an Effective Management of Infected Patients in Sub-Sahara AfricaClinicalTrials.gov ↗Phase 3, 300 participants, Completed
- Clinical trialImpact of Different Treatment Modalities on Immunity Against COVID-19ClinicalTrials.gov ↗Phase 2, 150 participants, Completed
- ClinicalTrials.gov ↗
- Clinical trialPhase II, Open Label, Randomized Study of Azithromycin Combination Therapy for the Treatment of Acute, Uncomplicated Falciparum MalariaClinicalTrials.gov ↗Phase 2, 120 participants, Completed
- Clinical trialA Randomized, Two-way Crossover Design Used to Compare the Dose Proportionality of Quinine Sulfate Capsules, 324 mg Following a Single Oral Dose of 1 x 324 mg Capsule Versus 2 x 324 mg Capsules in Healthy Adult VolunteersClinicalTrials.gov ↗Phase 1, 24 participants, Completed
- Clinical trialA Relative Bioavailability Study of Quinine Sulfate Capsules 324mg Under Fasting and Fed ConditionsClinicalTrials.gov ↗Phase 1, 22 participants, Completed
- ClinicalTrials.gov ↗
- Clinical trialBrain Responses to Intragastric Administration of a Bitter Agonist in Homeostatic and Hedonic Brain RegionsClinicalTrials.gov ↗15 participants, Completed
- Clinical trialEffects of Intragastric Quinine, Alone or Combined With L-leucine, on Postprandial Glycaemic ControlClinicalTrials.gov ↗15 participants, Completed
- Clinical trialThe Influence of Bitter Substrates on Hunger, Gastrointestinal Hormone Release and Hedonic Food IntakeClinicalTrials.gov ↗Phase 4, 14 participants, Completed
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
Problems people have reported.
Read this carefully. These are 33,097 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Quinine is, not how risky it is. A report is not proof Quinine caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.